Patents Assigned to MORPHOSYS GMBH
  • Eluate collection during antibody chromatography
    Patent number: 12760063
    Abstract: The present invention relates to an improved method for peak fractionation and eluate collection during chromatography for purification of a human therapeutic antibody.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: October 13, 2026
    Assignee: MorphoSys GmbH
    Inventors: Daniela Daubert, Dominik Geltinger, Karin Felderer
  • Complex-specific antibodies and antibody fragments and its use
    Patent number: 12590172
    Abstract: The present invention provides antibodies and fragments thereof that specifically detect the complex of a specific cognate antigen-binding moiety, in particular antibodies, and its antigen. The antibodies of the present disclosure do not bind either said cognate antigen binding moiety or said antigen alone and this can be used e.g. to directly detect antigen-bound antigen-binding moieties. Further disclosed are methods for production and use of said antibodies and antibody fragments.
    Type: Grant
    Filed: March 30, 2023
    Date of Patent: March 31, 2026
    Assignee: MORPHOSYS GMBH
    Inventors: Stefan Haertle, Christian Frisch, Achim Knappik